Ascendis Pharma A/S News

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 19 16:11 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(16.1%),Peter Kolchinsky(16.1%), etc.

Nov 14 17:51 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14 16:59 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14 16:23 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.0%)

Nov 14 15:02 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(2.9%)

Nov 14 13:34 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(8.2%),Behzad Aghazadeh(8.2%)

Nov 14 09:36 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 13 16:10 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Artisan Partners Limited Partnership(7.3%),Artisan Investments GP LLC(7.3%), etc.

Nov 12 09:55 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(2.21%),Wellington Group Holdings LLP(2.21%), etc.

Nov 8 10:40 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 4 07:09 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 9 16:02 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 30 08:38 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 27 17:04 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 23 16:04 ET

Ascendis Pharma A/S | 424B5: Prospectus

Sep 20 16:03 ET

Ascendis Pharma A/S | 424B5: Prospectus

Sep 18 17:22 ET

Ascendis Pharma A/S | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Sep 18 16:03 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 16 07:36 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 16 07:31 ET